Sunlight in Small Doses: Balancing Health Benefits and Dermatologic Risks
Kristina Mueller, Valerie FoyABSTRACT
Background
Sunlight exposure presents a dual challenge in dermatology: it is the primary modifiable risk factor for skin cancer, yet it provides essential systemic health benefits, including vitamin D synthesis and potential mental health advantages. Controlled “microdosing” of sunlight may help balance these risks and benefits.
Objective
This review highlights the physical and mental health benefits of limited sun exposure and evaluates practical frameworks for safe, personalized sun exposure.
Methods
A narrative review was conducted examining sub‐erythemal ultraviolet‐B (UVB) doses required for maintaining endogenous vitamin D levels. Key frameworks analyzed include the ¼ minimum erythema dose (MED) rule and the standardized erythema dose (SED) approach based on the UV Index (UVI). Factors influencing safe exposure (skin type, season, geographic location, and prior skin disease history) were considered.
Results
Sub‐erythemal UVB doses vary significantly by individual and environmental factors. The ¼ MED rule offers a practical estimate but remains influenced by personal variability and conditions. The SED/UVI‐based method provides a more standardized alternative, independent of many patient‐specific variables. The combined use of the MED and SED frameworks supports individualized sun exposure guidance.
Conclusion
MED and SED‐based approaches together offer a balanced framework for personalized sun exposure that minimizes skin cancer risk while preserving systemic health benefits. These strategies can guide public health recommendations and clinical practice.